• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Revalesio Presents New Ph 2 Data on RNS60 in Acute Ischemic Stroke

    PR NEWSWIRE

    Revalesio`s Investigational Treatment Protects Mitochondria In Model

    PR NEWSWIRE

    Revalesio’s RNS60 Extended ALS Survival In Post-Hoc Analysis Of Phase 2 Trial

    PR NEWSWIRE

    Revalesio Announces Positive Topline Data From Phase 2 Rescue Study Of Rns60

    PR NEWSWIRE

    Revalesio Shows Design of RESCUE Phase 2 Trial of RNS60 in Acute Ischemic Stroke

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.